Takeda Pharmaceutical Company Limited ( TAK) - Stock Earnings
TAK Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| July 30, 2026, midnight | — / — | — | — / — | — |
TAK Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q2 | 863.9 million USD | 7.7 billion USD |
| 2025Q3 | -79.7 million USD | 7.5 billion USD |
| 2025Q4 | 673.5 million USD | 7.7 billion USD |
| 2026Q3 Est. | — | — |
TAK Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 2.4 billion USD | 30.3 billion USD |
| 2024 | 951.5 million USD | 28.2 billion USD |
| 2025 | 722.6 million USD | 30.7 billion USD |
| 2026 Est. | — | — |
TAK
Price: $16.87
Dividend Yield: 3.76%
Forward Dividend Yield: 3.58%
Payout Ratio: 177.09%
Dividend Per Share: 0.62 USD
Earnings Per Share: 0.38 USD
P/E Ratio: 43.63
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: Japan
Volume: 2.3 million
Market Capitalization: 53.0 billion
Average Dividend Frequency: 2
Years Paying Dividends: 19
DGR3: -2.55%
DGR5: -3.99%
DGR10: -5.34%